Avanos Medical (NYSE:AVNS) Releases Quarterly Earnings Results

Avanos Medical (NYSE:AVNS) issued its quarterly earnings results on Wednesday. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03, Zacks reports. The firm had revenue of $179.60 million during the quarter, compared to the consensus estimate of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Avanos Medical updated its FY 2025 guidance to 1.050-1.250 EPS.

Avanos Medical Trading Down 0.8 %

Avanos Medical stock traded down $0.12 during trading hours on Friday, reaching $15.09. The company had a trading volume of 93,296 shares, compared to its average volume of 545,667. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.46. Avanos Medical has a 12-month low of $14.40 and a 12-month high of $25.36. The company has a 50-day moving average price of $16.12 and a 200 day moving average price of $19.67. The firm has a market cap of $693.54 million, a price-to-earnings ratio of 44.38 and a beta of 0.98.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.